Atai Life Sciences acquires exclusive rights to Psilera’s DMT patent portfolio

Atai Life Sciences has taken a strategic step in expanding its position in psychedelic medicine by securing exclusive rights to Psilera Inc.’s DMT patent portfolio. ... Read More